Lyssikatos Joseph P

Enliven Therapeutics, Inc. · CHIEF SCIENTIFIC OFFICER

Lyssikatos Joseph P is listed in public filings as officer: CHIEF SCIENTIFIC OFFICER. This Lyssikatos Joseph P insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Enliven Therapeutics, Inc. (ELVN). Investors use Lyssikatos Joseph P's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

History Trades

CompanyValueActionPriceCurrent Price
Enliven Therapeutics, Inc.ELVN$390k14.5k sharesSellJan 20, 2026$26.90--
Enliven Therapeutics, Inc.ELVN$145k5.5k sharesSellJan 20, 2026$26.37--
Enliven Therapeutics, Inc.ELVN$1.5M50k sharesSellJan 9, 2026$29.13--
Enliven Therapeutics, Inc.ELVN$1.0M41.2k sharesSellJan 9, 2026$24.90--
Enliven Therapeutics, Inc.ELVN$842k33.8k sharesSellJan 8, 2026$24.92--
Enliven Therapeutics, Inc.ELVN$151k7.5k sharesSellJan 8, 2026$20.13--
Enliven Therapeutics, Inc.ELVN$84k5k sharesSellDec 19, 2025$16.84--
Enliven Therapeutics, Inc.ELVN$268k12k sharesSellNov 19, 2025$22.30--
Enliven Therapeutics, Inc.ELVN$11k492 sharesSellNov 19, 2025$23.09--
Enliven Therapeutics, Inc.ELVN$276k12.5k sharesSellOct 20, 2025$22.08--
Enliven Therapeutics, Inc.ELVN$81k4k sharesSellSep 26, 2025$20.25--
Enliven Therapeutics, Inc.ELVN$30k1.5k sharesSellSep 23, 2025$20.03--
Enliven Therapeutics, Inc.ELVN$93k4.9k sharesSellSep 19, 2025$19.11--
Enliven Therapeutics, Inc.ELVN$43k2.1k sharesSellSep 19, 2025$20.02--
Enliven Therapeutics, Inc.ELVN$150k7.5k sharesSellAug 21, 2025$20.01--
Enliven Therapeutics, Inc.ELVN$98k5k sharesSellAug 19, 2025$19.62--
Enliven Therapeutics, Inc.ELVN$265k11.9k sharesSellJul 21, 2025$22.26--
Enliven Therapeutics, Inc.ELVN$13k576 sharesSellJul 21, 2025$22.90--
Enliven Therapeutics, Inc.ELVN$267k12.5k sharesSellJun 20, 2025$21.40--
Enliven Therapeutics, Inc.ELVN$150k7.5k sharesSellJun 3, 2025$20.03--
Enliven Therapeutics, Inc.ELVN$82k5k sharesSellMay 19, 2025$16.31--
Enliven Therapeutics, Inc.ELVN$49k2.5k sharesSellMay 2, 2025$20.01--
Enliven Therapeutics, Inc.ELVN$101k5k sharesSellMay 1, 2025$20.07--
Enliven Therapeutics, Inc.ELVN$75k4.7k sharesSellApr 21, 2025$16.03--
Enliven Therapeutics, Inc.ELVN$5.5k330 sharesSellApr 21, 2025$16.72--
Enliven Therapeutics, Inc.ELVN$258k12.5k sharesSellMar 19, 2025$20.61--
Enliven Therapeutics, Inc.ELVN$25k847 sharesSellOct 18, 2024$30.00--
Enliven Therapeutics, Inc.ELVN$964k34.3k sharesSellOct 9, 2024$28.12--
Enliven Therapeutics, Inc.ELVN$102k3.6k sharesSellOct 9, 2024$28.52--
Enliven Therapeutics, Inc.ELVN$368k13.2k sharesSellOct 8, 2024$27.96--
Enliven Therapeutics, Inc.ELVN$2.9k100 sharesSellOct 8, 2024$28.51--
Enliven Therapeutics, Inc.ELVN$75k2.7k sharesSellOct 7, 2024$27.61--
Enliven Therapeutics, Inc.ELVN$207k7.5k sharesSellOct 4, 2024$27.51--
Enliven Therapeutics, Inc.ELVN$15k527 sharesSellOct 1, 2024$27.54--
Enliven Therapeutics, Inc.ELVN$269k12k sharesSellAug 29, 2024$22.48--
Enliven Therapeutics, Inc.ELVN$1.2k50 sharesSellAug 29, 2024$23.08--
Enliven Therapeutics, Inc.ELVN$85k3.1k sharesSellJul 31, 2024$27.56--
Enliven Therapeutics, Inc.ELVN$315k11.8k sharesSellJul 29, 2024$26.69--
Enliven Therapeutics, Inc.ELVN$5.6k203 sharesSellJul 29, 2024$27.43--
Enliven Therapeutics, Inc.ELVN$275k12k sharesSellJul 1, 2024$22.89--